List of medicines currently in PRIME scheme
Submitted by Anonymous (not verified) on 3 April 2024 - 15:48
List of medicines currently in PRIME scheme
Human medicines European public assessment report (EPAR): Ertapenem SUN, ertapenem, Date of authorisation: 15/07/2022, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 3 April 2024 - 15:17
Human medicines European public assessment report (EPAR): Ertapenem SUN, ertapenem, Date of authorisation: 15/07/2022, Revision: 2, Status: Authorised
List of medicines currently in PRIME scheme
Submitted by Anonymous (not verified) on 3 April 2024 - 14:32
List of medicines currently in PRIME scheme
Veterinary medicines European public assessment report (EPAR): Bovilis Nasalgen-C, bovine coronavirus, strain CA25, live, Status: Authorised
Submitted by Anonymous (not verified) on 3 April 2024 - 14:15
Veterinary medicines European public assessment report (EPAR): Bovilis Nasalgen-C, bovine coronavirus, strain CA25, live, Status: Authorised
Committee for Orphan Medicinal Products (COMP): 13-15 February 2024, European Medicines Agency, Amsterdam, the Netherlands, from 13 February 2024 to 15 February 2024
Submitted by Anonymous (not verified) on 3 April 2024 - 11:55
Committee for Orphan Medicinal Products (COMP): 13-15 February 2024, European Medicines Agency, Amsterdam, the Netherlands, from 13 February 2024 to 15 February 2024
Marketing authorisation templates
Submitted by Anonymous (not verified) on 3 April 2024 - 10:49
Marketing authorisation templates
Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)
Submitted by Anonymous (not verified) on 3 April 2024 - 10:22
Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)
Orphan designation: Cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinolin-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide, (L)-malate salt (cabozantinib) Treatment of medullary thyroid carcinoma, 06/02/2009 Positive
Submitted by Anonymous (not verified) on 2 April 2024 - 12:00
Orphan designation: Cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinolin-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide, (L)-malate salt (cabozantinib) Treatment of medullary thyroid carcinoma, 06/02/2009 Positive
Herbal medicinal product: MyrrhaArray, C: ongoing call for scientific data
Submitted by Anonymous (not verified) on 2 April 2024 - 10:46
Herbal medicinal product: MyrrhaArray, C: ongoing call for scientific data
Herbal medicinal product: Melissae foliumArray, C: ongoing call for scientific data
Submitted by Anonymous (not verified) on 2 April 2024 - 10:46
Herbal medicinal product: Melissae foliumArray, C: ongoing call for scientific data